Apixaban-Induced Hepatotoxicity

Apixaban is widely used to prevent and manage thromboembolic disease. Due to it being fairly new in the market, we are still understanding its complete risk profile. We present a case of a 61-year-old female with no prior history of liver disease, who developed severe transaminitis shortly after the...

Descripción completa

Detalles Bibliográficos
Autores principales: Ansari, Umair, Asghar, Zahra, Oswald, Meghan, Ng, Hong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2022
Materias:
Cardiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8985735/
https://www.ncbi.nlm.nih.gov/pubmed/35402115
http://dx.doi.org/10.7759/cureus.23879
_version_ 1784682410334486528
author Ansari, Umair
Asghar, Zahra
Oswald, Meghan
Ng, Hong
author_facet Ansari, Umair
Asghar, Zahra
Oswald, Meghan
Ng, Hong
author_sort Ansari, Umair
collection PubMed
description Apixaban is widely used to prevent and manage thromboembolic disease. Due to it being fairly new in the market, we are still understanding its complete risk profile. We present a case of a 61-year-old female with no prior history of liver disease, who developed severe transaminitis shortly after the initiation of apixaban and started trending down after its discontinuation.
format Online
Article
Text
id pubmed-8985735
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-89857352022-04-08 Apixaban-Induced Hepatotoxicity Ansari, Umair Asghar, Zahra Oswald, Meghan Ng, Hong Cureus Cardiology Apixaban is widely used to prevent and manage thromboembolic disease. Due to it being fairly new in the market, we are still understanding its complete risk profile. We present a case of a 61-year-old female with no prior history of liver disease, who developed severe transaminitis shortly after the initiation of apixaban and started trending down after its discontinuation. Cureus 2022-04-06 /pmc/articles/PMC8985735/ /pubmed/35402115 http://dx.doi.org/10.7759/cureus.23879 Text en Copyright © 2022, Ansari et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Cardiology
Ansari, Umair
Asghar, Zahra
Oswald, Meghan
Ng, Hong
Apixaban-Induced Hepatotoxicity
title Apixaban-Induced Hepatotoxicity
title_full Apixaban-Induced Hepatotoxicity
title_fullStr Apixaban-Induced Hepatotoxicity
title_full_unstemmed Apixaban-Induced Hepatotoxicity
title_short Apixaban-Induced Hepatotoxicity
title_sort apixaban-induced hepatotoxicity
topic Cardiology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8985735/
https://www.ncbi.nlm.nih.gov/pubmed/35402115
http://dx.doi.org/10.7759/cureus.23879
work_keys_str_mv AT ansariumair apixabaninducedhepatotoxicity
AT asgharzahra apixabaninducedhepatotoxicity
AT oswaldmeghan apixabaninducedhepatotoxicity
AT nghong apixabaninducedhepatotoxicity

Ejemplares similares